Neuropace (NPCE) insider trading in the last 6 months
3 insiders bought $302K. No sales.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Who files at Neuropace
Cluster buys at NPCE
3 insiders bought NPCE in the last 6 months: R. Scott Huennekens, Joel Becker, and Patrick F. Williams.
Questions about NPCE's insider trades
Are NPCE insiders buying or selling?
3 insiders bought $302K across 3 filings in the last 6 months. No open-market sales on record. The newest filing: R. Scott Huennekens, Director, bought $104K on Nov 18, 2026. 3 insiders bought NPCE in the last 6 months: R. Scott Huennekens, Joel Becker, and Patrick F. Williams.
Who are NPCE's biggest insider sellers?
No NPCE insider sold shares on the open market in the last 6 months, as filed on Form 4.
When did an NPCE insider last buy?
R. Scott Huennekens, Director, bought NPCE shares ($104K) on Nov 18, 2026, the newest insider buy on record.
Neuropace's page has its Quality Score, its chart, and its earnings. More in Healthcare and Medical Devices. NPCE is on this week's insider buys.